• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅因子结合及活性位点占据对凝血因子VIIa大分子底物外位点构象的影响。

Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.

作者信息

Dickinson C D, Shobe J, Ruf W

机构信息

Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

J Mol Biol. 1998 Apr 10;277(4):959-71. doi: 10.1006/jmbi.1998.1639.

DOI:10.1006/jmbi.1998.1639
PMID:9545384
Abstract

The catalytic activity of the trypsin-like serine protease coagulation factor VIIa is allosterically regulated. In this work, we employed monoclonal antibodies as probes to analyze conformational changes in the VII protease domain that are induced by zymogen activation, cofactor tissue factor (TF) binding, and active site occupancy. The epitopes of three monoclonal antibodies were mapped using a panel of 57 individual alanine replacement mutants in the protease domain. Two of the antibodies had typical "hot spot" epitopes in a basic cluster above the active site cleft and antibody binding to these epitopes was not affected by zymogen activation, TF binding, or active site occupancy. In contrast, the binding kinetics of VII/VIIa to a monoclonal antibody that mapped to an extended epitope overlapping with the macromolecular substrate exosite was affected by each of the conformational transitions of the VIIa protease domain. The changes in antibody affinity are consistent with a transition from zymogen VII to the TF.VIIa complex, with free enzyme VIIa as an intermediate that retains some zymogen-like features responsible for its low catalytic activity. In contrast, active site occupancy resulted in effects that were qualitatively different from the effects of zymogen activation on the antibody epitope. This provides novel insight into the conformational interdependence between the active site, the region for macromolecular substrate recognition, and the cofactor binding exosite of this allosterically regulated serine protease.

摘要

类胰蛋白酶丝氨酸蛋白酶凝血因子VIIa的催化活性受到别构调节。在本研究中,我们使用单克隆抗体作为探针,分析由酶原激活、辅因子组织因子(TF)结合和活性位点占据诱导的VII蛋白酶结构域的构象变化。使用蛋白酶结构域中的一组57个单个丙氨酸替代突变体对三种单克隆抗体的表位进行了定位。其中两种抗体在活性位点裂隙上方的碱性簇中有典型的“热点”表位,并且抗体与这些表位的结合不受酶原激活、TF结合或活性位点占据的影响。相比之下,VII/VIIa与一种单克隆抗体的结合动力学,该抗体的表位定位在与大分子底物外位点重叠的延伸表位上,受到VIIa蛋白酶结构域的每种构象转变的影响。抗体亲和力的变化与从酶原VII到TF.VIIa复合物的转变一致,游离酶VIIa作为中间体,保留了一些导致其低催化活性的类酶原特征。相比之下,活性位点的占据导致的效应在性质上与酶原激活对抗体表位的效应不同。这为这种别构调节的丝氨酸蛋白酶的活性位点、大分子底物识别区域和辅因子结合外位点之间的构象相互依赖性提供了新的见解。

相似文献

1
Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.辅因子结合及活性位点占据对凝血因子VIIa大分子底物外位点构象的影响。
J Mol Biol. 1998 Apr 10;277(4):959-71. doi: 10.1006/jmbi.1998.1639.
2
Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.凝血因子VII和凝血因子VIIa与组织因子区域的类似分子相互作用,该区域通过变构调节酶活性。
Biochemistry. 2004 Feb 10;43(5):1223-9. doi: 10.1021/bi035738i.
3
Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site.通过表面残基Glu 154与活性位点的构象连接对凝血因子VIIa催化功能的调节。
Biochemistry. 1999 Mar 2;38(9):2745-51. doi: 10.1021/bi981951g.
4
Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.导致组织因子表达的细胞免疫和细胞因子途径及其与脓毒性休克的相关性。
Nouv Rev Fr Hematol (1978). 1992;34 Suppl:S15-27.
5
The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.凝血因子VIIa的催化裂隙和外位点残基在与组织因子途径抑制剂形成复合物中的作用。
Thromb Haemost. 2001 Mar;85(3):458-63.
6
Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.蛋白质二聚化导致活性位点抑制的因子VIIa功能活性大幅增强:对组织因子组装/拆卸机制的见解
Biochemistry. 2005 Apr 26;44(16):6321-30. doi: 10.1021/bi050007z.
7
Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.通过占据组织因子上一个新的肽基对接位点,对组织因子驱动的凝血蛋白酶级联反应的外源性途径进行选择性衰减。
Biochemistry. 2003 Sep 16;42(36):10619-26. doi: 10.1021/bi034910f.
8
Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.因子VIIa抑制剂会影响蛋白酶结构域与组织因子之间的界面。
Biochem Biophys Res Commun. 2006 Oct 27;349(3):1111-6. doi: 10.1016/j.bbrc.2006.08.148. Epub 2006 Sep 1.
9
Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.凝血因子VIIaγ-羧基谷氨酸结构域中精氨酸-36残基对大分子底物凝血因子Xγ-羧基谷氨酸结构域识别的重要性。
Biochemistry. 1999 Feb 16;38(7):1957-66. doi: 10.1021/bi982254r.
10
Current status on tissue factor activation of factor VIIa.组织因子 VIIa 激活的现状。
Thromb Res. 2010 Apr;125 Suppl 1:S11-2. doi: 10.1016/j.thromres.2010.01.023. Epub 2010 Feb 13.

引用本文的文献

1
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.CD248 增强组织因子促凝功能,促进小鼠模型的动静脉血栓形成。
J Thromb Haemost. 2021 Aug;19(8):1932-1947. doi: 10.1111/jth.15338. Epub 2021 May 7.
2
Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.组织因子途径抑制剂使单核细胞对抗磷脂抗体诱导的血栓形成敏感。
Blood. 2019 Oct 3;134(14):1119-1131. doi: 10.1182/blood.2019001530. Epub 2019 Aug 21.
3
Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
鉴定凝血因子 VIIa 上整合素结合位点对于 PAR2 信号的促血管生成作用是必需的。
Blood. 2018 Feb 8;131(6):674-685. doi: 10.1182/blood-2017-02-768218. Epub 2017 Dec 15.
4
Engineering of a membrane-triggered activity switch in coagulation factor VIIa.工程化凝血因子 VIIa 的膜触发活性开关。
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12454-12459. doi: 10.1073/pnas.1618713114. Epub 2017 Nov 6.
5
The transition of prothrombin to thrombin.凝血酶原向凝血酶的转化。
J Thromb Haemost. 2013 Jun;11 Suppl 1(0 1):265-76. doi: 10.1111/jth.12217.
6
A reverse binding motif that contributes to specific protease inhibition by antibodies.一种反向结合基序,有助于抗体对特定蛋白酶的抑制作用。
J Mol Biol. 2012 Jan 27;415(4):699-715. doi: 10.1016/j.jmb.2011.11.036. Epub 2011 Nov 27.
7
Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.针对尿激酶型纤溶酶原激活物的自溶环的构象特异性单克隆抗体。
Biochem J. 2011 Aug 15;438(1):39-51. doi: 10.1042/BJ20110129.
8
Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.PAR2 胞外结构域与因子 VIIa 相互作用的分子动力学模拟及功能特征分析。
Proteins. 2009 Nov 15;77(3):559-69. doi: 10.1002/prot.22468.
9
Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity.钙离子诱导增强内源性凝血因子VIIa活性的机制。
J Biol Chem. 2008 Sep 19;283(38):25863-70. doi: 10.1074/jbc.M800841200. Epub 2008 Jul 17.
10
Structural insight into distinct mechanisms of protease inhibition by antibodies.抗体抑制蛋白酶不同机制的结构洞察
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19784-9. doi: 10.1073/pnas.0708251104. Epub 2007 Dec 5.